Company / Operating Margin
Gilead Sciences Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
34.0%
FY2025
5-year range
5.8% / 36.3%
FY2021-FY2025
Trend
+488.9%
vs FY2024
Sector context
#14 of 136
Health Care
What the data says
Operating Margin changed +489% YoY in FY2025, a notable deviation from the 9-year average annual change of +50%.
Based on SEC 10-K filings.
34.0% in FY2025 with a 5-year CAGR of +17.5%. Top quartile in the Health Care sector.
Declined from 36.3% to 34.0% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +17.5pp
- 5-Year Change
- +17.5pp
- 10-Year Change
- -
Sector benchmark
Top 10% in Health CareTop 10% of 136This company 34.0% Sector average -778.9%
▼
+104.4% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 488.9% year-over-year.
- Currently 813.0pp above the Health Care sector average.
- Peak operating margin was recorded in FY2017.
- Lowest operating margin in the period was in FY2024.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 34.0% | +488.9% |
| FY2024 | 5.8% | -84.1% |
| FY2023 | 36.3% | +120.3% |
| FY2022 | 16.5% | -13.7% |
| FY2021 | 19.1% | +15.8% |
| FY2020 | 16.5% | -69.5% |
| FY2019 | 54.1% | -6.8% |
| FY2018 | 58.0% | -14.7% |
| FY2017 | 68.0% | +10.9% |
| FY2016 | 61.3% | -9.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026